Review

Therapeutic potential of apigenin in neurodegenerative diseases and brain health

Mohannad A. Aldiqs Mansur Aliev Tushar B. Gajjar J. N. Senapati Bahjat Alhasso Dilbar Urazbaeva Shakhrijakhon Aminqulov Manoj Kumar Mishra

Sep 2026 · Molecular Biology Reports · Vol 53 · 0 citations · 101 references

Medicine

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

Medicinal Plants and Bioactive Phytochemicals Targeting Neuroinflammation: Molecular Mechanisms, Preclinical Evidence and Translational Challenges

An in-depth review of medicinal plants with anti-neuroinflammatory properties, focusing on their bioactive compounds, mode of action, and clinical applications in neurological disorders is given.

Owemidu Idowu Olumorin · Nigerian Journal of Biotechn... · 0 citations

Review Sep 2026

Postbiotics as a therapeutic frontier in Parkinson’s disease: Insights into molecular pathways and neuroprotective effects

Overall, postbiotics may represent a promising therapeutic strategy for targeting neurodegenerative processes in PD, although their safety, efficacy, optimal dosing, and clinical utility require further investigations.

Anjali Kumari, K. Aran · Metabolic brain disease · 0 citations

Review Open access Sep 2026

Plant-Derived Bioactive Compounds in Aging: Shared Mechanism Linking Cardiovascular and Neurodegenerative Diseases

Findings support the concept that antioxidant and anti-inflammatory pathways constitute a unifying framework linking aging to chronic disease progression and promote healthy aging.

R. Trigueiro, Liz Oliveira, P. Newman · Advances in Geriatric Medici... · 0 citations

Review Open access Sep 2026

Role of arbutin and acetoside against Parkinson’s disease

Computer docking reports have revealed positive results between arbutin, acetoside, and key targets of PD, and phenolic glycosides are highlighted as promising multitarget neuroprotective candidates for PD.

Anish Singh, Diksha Dalal, Lovedeep Singh · Indian Journal of Pharmacolo... · 0 citations

Review Aug 2026

Hesperidin as a Neuroprotective Agent in Parkinson’s Disease: Mechanistic Insights and In Silico Validation

Combined in silico and experimental findings highlight hesperidin’s strong binding to key molecular targets, whereas experimental evidence also confirms its antioxidant, anti-inflammatory, and anti-apoptotic effects, supporting its potential as a disease-modifying candidate in PD therapy.

Seyawash Ghani, Diksha Dalal, Anish Singh et al. · Current Behavioral Neuroscie... · 0 citations

Review Sep 2026

Repurposing Antidiabetic Drugs in Neurodegenerative Disorders: From Preclinical Mechanisms to Clinical Evidence

The present review aims to summarize the molecular mechanisms behind the neuroprotective activity and potential application of various antidiabetics in neurodegenerative diseases, namely metformin, liraglutide, pioglitazone, linagliptin, dapagliflozin, glibenclamide, exenatide, and imeglimin.

D. Devi, Ankita Rani, Jiten Singh et al. · SN Comprehensive Clinical Me... · 0 citations